1,251 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Myriad Acquisitions

Myriad has acquired 6 companies and its latest acquisition was Gateway Genomics, LLC on Nov 2022

Unlock 3 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Gateway Genomics, LLC

Nov 2022

Source »
undisclosed
Gateway Genomics is a California-based biotechnology firm that develops and commercializes non-invasive prenatal and early gender DNA test kits for parents.
Counsyl, Inc.

May 2018

Source »
$375M
Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.
Assurex Health, Inc.

Aug 2016

Source »
$225M
AssureRx Health is a precision medicine company that specializes in pharmacogenomics for behavioral health and chronic pain.
Sividon Diagnostics

May 2016

Source »
$38.9M
Sividon Diagnostics develops and commercializes genomic-based diagnostic test for breast cancer treatment.
Crescendo Bioscience, Inc.

Feb 2014

Source »
$270M
Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases.

Frequently Asked Questions about Myriad

  1. What companies did Myriad acquire?

    Companies acquired by Myriad include Gateway Genomics, Counsyl and GeneSight

  2. How many acquisitions does Myriad have?

    Myriad has acquired 6 companies including Gateway Genomics, Counsyl and GeneSight.

  1. How many acquisitions did Myriad make in 2022?

    In 2022 Myriad acquired 1 companies including Gateway Genomics.